108 related articles for article (PubMed ID: 17989713)
1. The prevalence of IG translocations and 7q32 deletions in splenic marginal zone lymphoma.
Remstein ED; Law M; Mollejo M; Piris MA; Kurtin PJ; Dogan A
Leukemia; 2008 Jun; 22(6):1268-72. PubMed ID: 17989713
[No Abstract] [Full Text] [Related]
2. Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis.
Watkins AJ; Huang Y; Ye H; Chanudet E; Johnson N; Hamoudi R; Liu H; Dong G; Attygalle A; McPhail ED; Law ME; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
J Pathol; 2010 Mar; 220(4):461-74. PubMed ID: 20077527
[TBL] [Abstract][Full Text] [Related]
3. High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma.
Fresquet V; Robles EF; Parker A; Martinez-Useros J; Mena M; Malumbres R; Agirre X; Catarino S; Arteta D; Osaba L; Mollejo M; Hernandez-Rivas JM; Calasanz MJ; Daibata M; Dyer MJ; Prosper F; Vizcarra E; Piris MÁ; Oscier D; Martinez-Climent JA
Br J Haematol; 2012 Sep; 158(6):712-26. PubMed ID: 22816737
[TBL] [Abstract][Full Text] [Related]
4. Translocation t(9;14)(p13;q32) in cases of splenic marginal zone lymphoma.
Baró C; Salido M; Domingo A; Granada I; Colomo L; Serrano S; Solé F
Haematologica; 2006 Sep; 91(9):1289-91. PubMed ID: 16956840
[TBL] [Abstract][Full Text] [Related]
5. Deletion mapping on the long arm of chromosome 7 in splenic lymphoma with villous lymphocytes.
Gruszka-Westwood AM; Hamoudi R; Osborne L; Matutes E; Catovsky D
Genes Chromosomes Cancer; 2003 Jan; 36(1):57-69. PubMed ID: 12461750
[TBL] [Abstract][Full Text] [Related]
6. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ
Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of the region 7q22.1 in splenic marginal zone lymphomas.
Robledo C; García JL; Benito R; Flores T; Mollejo M; Martínez-Climent JÁ; García E; Gutiérrez NC; Piris MA; Hernández JM
PLoS One; 2011; 6(9):e24939. PubMed ID: 21957467
[TBL] [Abstract][Full Text] [Related]
8. Absence of mutations of the histone methyltransferase gene EZH2 in splenic b-cell marginal zone lymphoma.
Salido M; Martinez-Avilés L; Ademà V; Ferrer A; Espinet B; Garcia M; Salar A; Besses C; Florensa L; Serrano S; Bellosillo B; Solé F
Leuk Res; 2011 Mar; 35(3):e23-4. PubMed ID: 21087793
[No Abstract] [Full Text] [Related]
9. Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations.
Corcoran MM; Mould SJ; Orchard JA; Ibbotson RE; Chapman RM; Boright AP; Platt C; Tsui LC; Scherer SW; Oscier DG
Oncogene; 1999 Nov; 18(46):6271-7. PubMed ID: 10597225
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA losses in the frequently deleted region of 7q in SMZL.
Ruiz-Ballesteros E; Mollejo M; Mateo M; Algara P; Martínez P; Piris MA
Leukemia; 2007 Dec; 21(12):2547-9. PubMed ID: 17625607
[No Abstract] [Full Text] [Related]
11. Absence of MALT1 translocations in primary cutaneous marginal zone B-cell lymphoma.
Espinet B; Gallardo F; Pujol RM; Estrach T; Servitje O; Solé F
Haematologica; 2004 Sep; 89(9):ELT14. PubMed ID: 15377491
[TBL] [Abstract][Full Text] [Related]
12. Selection of antigen receptors in splenic marginal-zone lymphoma: further support from the analysis of the immunoglobulin light-chain gene repertoire.
Bikos V; Stalika E; Baliakas P; Darzentas N; Davis Z; Traverse-Glehen A; Dagklis A; Kanellis G; Anagnostopoulos A; Tsaftaris A; Ponzoni M; Berger F; Felman P; Ghia P; Papadaki T; Oscier D; Belessi C; Stamatopoulos K
Leukemia; 2012 Dec; 26(12):2567-9. PubMed ID: 22858907
[No Abstract] [Full Text] [Related]
13. Absence of ATM deletions in 16 cases of splenic marginal-zone B-cell lymphoma (SMZBCL).
Salido M; Astier L; Puigdecanet E; Espinet B; Florensa L; Solé F
Haematologica; 2003 Nov; 88(11):ELT33. PubMed ID: 14607769
[TBL] [Abstract][Full Text] [Related]
14. An integrated genomic and expression analysis of 7q deletion in splenic marginal zone lymphoma.
Watkins AJ; Hamoudi RA; Zeng N; Yan Q; Huang Y; Liu H; Zhang J; Braggio E; Fonseca R; de Leval L; Isaacson PG; Wotherspoon A; McPhail ED; Dogan A; Du MQ
PLoS One; 2012; 7(9):e44997. PubMed ID: 23028731
[TBL] [Abstract][Full Text] [Related]
15. Frequent involvement of chromosomes 1, 3, 7 and 8 in splenic marginal zone B-cell lymphoma.
Solé F; Woessner S; Florensa L; Espinet B; Mollejo M; Martín P; Piris MA
Br J Haematol; 1997 Aug; 98(2):446-9. PubMed ID: 9266948
[TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous marginal zone B-cell lymphoma may exhibit both the t(14;18)(q32;q21) IGH/BCL2 and the t(14;18)(q32;q21) IGH/MALT1 translocation: an indicator for clonal transformation towards higher-grade B-cell lymphoma?
Palmedo G; Hantschke M; Rütten A; Mentzel T; Kempf W; Tomasini D; Kutzner H
Am J Dermatopathol; 2007 Jun; 29(3):231-6. PubMed ID: 17519619
[TBL] [Abstract][Full Text] [Related]
17. FOXP1 status in splenic marginal zone lymphoma: a fluorescence in situ hybridization and immunohistochemistry approach.
Baró C; Espinet B; Salido M; Colomo L; Luño E; Florensa L; Ferrer A; Salar A; Campo E; Serrano S; Solé F
Histol Histopathol; 2009 Nov; 24(11):1399-404. PubMed ID: 19760589
[TBL] [Abstract][Full Text] [Related]
18. A narrow deletion of 7q is common to HCL, and SMZL, but not CLL.
Andersen CL; Gruszka-Westwood A; Østergaard M; Koch J; Jacobsen E; Kjeldsen E; Nielsen B
Eur J Haematol; 2004 Jun; 72(6):390-402. PubMed ID: 15128417
[TBL] [Abstract][Full Text] [Related]
19. The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma.
Piva R; Deaglio S; Famà R; Buonincontri R; Scarfò I; Bruscaggin A; Mereu E; Serra S; Spina V; Brusa D; Garaffo G; Monti S; Dal Bo M; Marasca R; Arcaini L; Neri A; Gattei V; Paulli M; Tiacci E; Bertoni F; Pileri SA; Foà R; Inghirami G; Gaidano G; Rossi D
Leukemia; 2015 Feb; 29(2):503-7. PubMed ID: 25283840
[No Abstract] [Full Text] [Related]
20. Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications.
Bikos V; Darzentas N; Hadzidimitriou A; Davis Z; Hockley S; Traverse-Glehen A; Algara P; Santoro A; Gonzalez D; Mollejo M; Dagklis A; Gangemi F; Bosler DS; Bourikas G; Anagnostopoulos A; Tsaftaris A; Iannitto E; Ponzoni M; Felman P; Berger F; Belessi C; Ghia P; Papadaki T; Dogan A; Degano M; Matutes E; Piris MA; Oscier D; Stamatopoulos K
Leukemia; 2012 Jul; 26(7):1638-46. PubMed ID: 22222599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]